PromoCell launches custom GMP cell culture media to power next-gen cell and gene therapies
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Investment to expand manufacturing and global medicine supply capacity
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Marks first international filing for Evofem’s single-dose oral treatment
Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
Subscribe To Our Newsletter & Stay Updated